Literature DB >> 15524172

Role of troponin T in disease.

Aldrin V Gomes1, Junor A Barnes, Keita Harada, James D Potter.   

Abstract

Several striated muscle myopathies have been directly linked to mutations in contractile and associated proteins. Troponin T (TnT) is one of the three subunits that form troponin (Tn) which together with tropomyosin is responsible for the regulation of striated muscle contraction. All three subunits of cardiac Tn as well as tropomyosin have been associated with hypertrophic cardiomyopathy (HCM). However, TnT accounts for most of the mutations that cause HCM in these regulatory proteins. To date 30 mutations have been identified in the cardiac TnT (CTnT) gene that results in familial HCM (FHC). The CTnT gene has also been associated with familial dilated cardiomyopathy (DCM). CTnT deficiency is lethal due to impaired cardiac development. A recessive nonsense mutation in the gene encoding slow skeletal TnT has been associated with an unusual, severe form of nemaline myopathy among the Old Order Amish. How each mutation leads to the diverse clinical symptoms associated with FHC, DCM or nemaline myopathy is unclear. However, the use of animal model systems, in particular transgenic mice, has significantly increased our knowledge of normal and myopathic muscle physiology. In this review, we focus on the role of TnT in muscle physiology and disease.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15524172     DOI: 10.1023/B:MCBI.0000041853.20588.a0

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  31 in total

1.  Cell-autonomous regulation of fast troponin T pre-mRNA alternative splicing in response to mechanical stretch.

Authors:  Rudolf J Schilder; Scot R Kimball; Leonard S Jefferson
Journal:  Am J Physiol Cell Physiol       Date:  2012-05-16       Impact factor: 4.249

2.  Effects of thin and thick filament proteins on calcium binding and exchange with cardiac troponin C.

Authors:  Jonathan P Davis; Catalina Norman; Tomoyoshi Kobayashi; R John Solaro; Darl R Swartz; Svetlana B Tikunova
Journal:  Biophys J       Date:  2007-02-09       Impact factor: 4.033

3.  Body weight-dependent troponin T alternative splicing is evolutionarily conserved from insects to mammals and is partially impaired in skeletal muscle of obese rats.

Authors:  Rudolf J Schilder; Scot R Kimball; James H Marden; Leonard S Jefferson
Journal:  J Exp Biol       Date:  2011-05-01       Impact factor: 3.312

4.  Pathogenesis associated with a restrictive cardiomyopathy mutant in cardiac troponin T is due to reduced protein stability and greatly increased myofilament Ca2+ sensitivity.

Authors:  Michelle S Parvatiyar; Jose Renato Pinto
Journal:  Biochim Biophys Acta       Date:  2014-11-01

Review 5.  Proteasome dysfunction in cardiomyopathies.

Authors:  Jennifer E Gilda; Aldrin V Gomes
Journal:  J Physiol       Date:  2017-03-16       Impact factor: 5.182

Review 6.  The myosin-activated thin filament regulatory state, M⁻-open: a link to hypertrophic cardiomyopathy (HCM).

Authors:  Sherwin S Lehrer; Michael A Geeves
Journal:  J Muscle Res Cell Motil       Date:  2014-04-17       Impact factor: 2.698

7.  Allosteric effects of cardiac troponin TNT1 mutations on actomyosin binding: a novel pathogenic mechanism for hypertrophic cardiomyopathy.

Authors:  Rachel K Moore; Salwa Abdullah; Jil C Tardiff
Journal:  Arch Biochem Biophys       Date:  2014-01-28       Impact factor: 4.013

8.  A model of calcium activation of the cardiac thin filament.

Authors:  Edward P Manning; Jil C Tardiff; Steven D Schwartz
Journal:  Biochemistry       Date:  2011-08-05       Impact factor: 3.162

9.  Structure and orientation of troponin in the thin filament.

Authors:  Danielle M Paul; Edward P Morris; Robert W Kensler; John M Squire
Journal:  J Biol Chem       Date:  2009-03-24       Impact factor: 5.157

10.  Cardiac muscle activation blunted by a mutation to the regulatory component, troponin T.

Authors:  Minae Kobayashi; Edward P Debold; Matthew A Turner; Tomoyoshi Kobayashi
Journal:  J Biol Chem       Date:  2013-07-29       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.